✦ LIBER ✦

Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C

✍ Scribed by Rebecca Townsend; Phil McEwan; Ray Kim; Yong Yuan

Book ID: 119309811
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 963 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.06.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response-guided peg-interferon plus riba

Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: Meta-analyses of randomized, controlled trials and implications for the future

✍ Vincent Di Martino; Carine Richou; Jean-Paul Cervoni; Jose M. Sanchez-Tapias; Do 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 1 views

Response-guided pegylated interferon (peg-IFN) plus ribavirin (P/R) therapy trials on genotype (G)1 and G2/G3 hepatitis C virus-infected patients provide contradictory results. We conducted meta-analyses of randomized, controlled trials to address (1) the benefit of a 72-week extended-duration thera

Using competence network collaboration a

Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon α-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany

✍ Uwe Siebert; Gaby Sroczynski; Jürgen Wasem; Wolfgang Greiner; Ulrike Ravens-Sieb 📂 Article 📅 2005 🏛 Springer 🌐 French ⚖ 261 KB

PGI18 Cost-Effectiveness of Boceprevir i

PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C: Submission to the National Institute for Health and Clinical Excellence (NICE)

✍ S.C. Humphreys; E.H. Elbasha; S.A. Ferrante; M. Lion; C. O'Regan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PIN50 The Clinical Efficacy and Cost-Eff

PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients: A Within Trial Analysis from the Perspective of the Scottish National Health Service (NHS)

✍ E. Nikoglou; S. Humphreys; A. El khoury; S.A. Ferrante; C. O' Regan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB